Literature DB >> 32624091

Development of a COVID-19 Point-of-Care Ultrasound Protocol.

Gary Huang1, Alexander Vengerovsky2, Amy Morris2, James Town2, David Carlbom2, Younghoon Kwon1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32624091      PMCID： PMC7177132          DOI： 10.1016/j.echo.2020.04.023

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN： 0894-7317            Impact factor:   5.251


× No keyword cloud information.
  6 in total

Review 1.  The role of PoCUS in the assessment of COVID-19 patients.

Authors:  John Karp; Karina Burke; Sarah-Marie Daubaras; Cian McDermott
Journal:  J Ultrasound       Date:  2021-04-19

Review 2.  A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis.

Authors:  Adedayo Adeboye; Deya Alkhatib; Asra Butt; Neeraja Yedlapati; Nadish Garg
Journal:  Diagnostics (Basel)       Date:  2022-02-21

Review 3.  Echocardiography in the Era of COVID-19: Lessons for the Future.

Authors:  Fitsumberhan Medhane; James N Kirkpatrick
Journal:  Curr Cardiol Rep       Date:  2021-10-16       Impact factor: 2.931

Review 4.  Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019.

Authors:  Sandeep S Hothi; Jin Jiang; Richard P Steeds; William E Moody
Journal:  Front Cardiovasc Med       Date:  2021-05-21

Review 5.  Heart failure in COVID-19 patients: Critical care experience.

Authors:  Kevin John John; Ajay K Mishra; Chidambaram Ramasamy; Anu A George; Vijairam Selvaraj; Amos Lal
Journal:  World J Virol       Date:  2022-01-25

6.  Cardiac point-of-care ultrasound in hospitalized coronavirus disease-2019 patients: findings and association with outcome.

Authors:  Vered Gilad; Vincenzo De Marzo; Giulia Guglielmi; Roberta Della Bona; Stefano Giovinazzo; Fabio Pescetelli; Alberto Valbusa; Gian Paolo Bezante; Andrea De Maria; Nicolò Patroniti; Diego Ferone; Paolo Pelosi; Matteo Bassetti; Italo Porto
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2022-01-01       Impact factor: 2.160
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.